Recently, the Hon’ble Barry O’Farrell, Australian High Commissioner to India, posted on Facebook that Australia was pleased to support COVAX Advance Market Commitment through an $80 million contribution.
Barry O’Farrell said:
“We are helping to ensure safe, effective and affordable COVID19 vaccines reach all countries around the world.”
GAVI, the Vaccine Alliance made news with the release of the first allocations of COVID19 vaccines through the COVAX Advance Market Commitment, manufactured by Serum Institute of India.
Gavi’s impact draws on the strengths of its core partners, the World Health Organization, UNICEF, the World Bank and the Bill & Melinda Gates Foundation.
It plays a critical role in strengthening primary health care (PHC), bringing us closer to the Sustainable Development Goal (SDG) of Universal Health Coverage (UHC), ensuring that no one is left behind.
Australia’s contribution is in addition to the $523 million that Australia is providing to the Pacific and Southeast Asia through the Regional Vaccine Access Initiative.
